Advertisement
Advertisement
SRTA
Strata Critical Medical, Inc. Class A Common Stock
5.09
USDSponsored
+0.22
+4.52%
Jul 30, 15:59 UTC -4
Closed
After-Market
5.09
0.00
0.00%
SRTA Earnings Reports
Positive Surprise Ratio
SRTA beat 9 of 17 last estimates.
53%
Next Report
Next Week
Date of Next Report
Aug 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
$68.39M
/$0.01
Implied change from Q1 26 (Revenue/ EPS)
+1.49%
/-66.67%
Implied change from Q2 25 (Revenue/ EPS)
-3.40%
/-120.00%
Strata Critical Medical, Inc. Class A Common Stock earnings per share and revenue
On May 06, 2026, SRTA reported earnings of 0.03 USD per share (EPS) for Q1 26, beating the estimate of -0.03 USD, resulting in a 178.33% surprise. Revenue reached 67.38 million, compared to an expected 64.95 million, with a 3.75% difference. The market reacted with a +10.58% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of 0.01 USD, with revenue projected to reach 68.39 million USD, implying an decrease of -66.67% EPS, and increase of 1.49% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Teladoc Health, Inc.
Report Date
Jul 29, 2026 For Q2 26
Estimate
-$0.25
Actual
-$0.21
Surprise
+17.61%
CareDx, Inc.
Report Date
Jul 30, 2026 For Q2 26
Estimate
$0.23
Actual
$0.37
Surprise
+55.79%
Danaher Corporation
Report Date
Jul 21, 2026 For Q2 26
Estimate
$1.85
Actual
$1.94
Surprise
+4.68%
HCA Healthcare, Inc.
Report Date
Jul 24, 2026 For Q2 26
Estimate
$7.54
Actual
$7.62
Surprise
+1.03%
Labcorp Holdings Inc.
Report Date
Jul 30, 2026 For Q2 26
Estimate
$4.92
Actual
$4.99
Surprise
+1.40%
Medpace Holdings, Inc. Common Stock
Report Date
Jul 22, 2026 For Q2 26
Estimate
$4.05
Actual
$4.25
Surprise
+4.93%
Bausch + Lomb Corporation
Report Date
Jul 29, 2026 For Q2 26
Estimate
$0.15
Actual
$0.16
Surprise
+3.03%
Avantor, Inc.
Report Date
Jul 29, 2026 For Q2 26
Estimate
$0.19
Actual
$0.21
Surprise
+8.58%
Alignment Healthcare, Inc. Common Stock
Report Date
Jul 30, 2026 For Q2 26
Estimate
$0.13
Actual
$0.17
Surprise
+28.79%
FAQ
What were Strata Critical Medical, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Strata Critical Medical, Inc. Class A Common Stock reported EPS of $0.03, beating estimates by 178.33%, and revenue of $67.38M, 3.75% above expectations.
How did the market react to Strata Critical Medical, Inc. Class A Common Stock's Q1 2026 earnings?
The stock price moved up 10.58%, changed from $4.82 before the earnings release to $5.33 the day after.
When is Strata Critical Medical, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Aug 04, 2026.
What are the forecasts for Strata Critical Medical, Inc. Class A Common Stock's next earnings report?
Based on 3
analysts, Strata Critical Medical, Inc. Class A Common Stock is expected to report EPS of $0.01 and revenue of $68.39M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement